Research.Patient.info
Pulmonary Fibrosis, Interstitial Lung Disease research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE2
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
This study looks into a new drug called Senicapoc for people with lung scarring diseases like pulmonary fibrosis. Researchers want to see if Senicapoc can stop the scarring from getting worse, compared to a dummy pill. It involves taking pills for 26 weeks and having check-ups.
Denmark · Estonia · United Kingdom - active not recruitingPHASE2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
This study is testing a new inhaled medicine (AP01) for people with progressive pulmonary fibrosis. It aims to see if it's safe and effective, compared to a dummy medicine, over one year, alongside usual care.
United States · Argentina · Australia